HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
- Type
- Retraction
- Notice date
- 8/15/2023 0:00
- Journal
- Journal of Hematology & Oncology
- Publisher
- Springer - Biomed Central (BMC)
- Notice DOI
- 10.1186/s13045-023-01493-7
- Original paper DOI
- 10.1186/s13045-020-00857-7